MPO- GROUP PRESENTATION

GROUP #10

MANISHA GARAI (PGDM-316)GUNISHA VISHNANI (PGDM-371)

DEBANJAN BOSE (PGDM-332)SAGAR RAUT (PGDM-301)

AWANTIKA MAURYA (PGDM-334)G.VENU MADHAV (PGDM-336)

KIRAN NIGAD (PGDM-377)MADHUR JAIN (PGDM-314)

SUN PHARMA

COMPANY PROFILE

Company Name

Sun Pharmaceutical Industries Ltd.

Country/Territory IndiaBusiness Type Pharmaceutical

Products/ServiceManufactures both Pharmaceutical and Active Pharmaceutical Ingredients (API)

Industry Focus Therapeutic areas including psychiatry,neorology,cardiology,diabetology,gastroentology,respiratory and orthopaedics

Geographical Market

World wide

Year Established 1983

Founder Dilip Shanghvi

SUN PHARMA’S GOBAL RANKING

OBJECTIVE OF THE PRESENTATION-

•SWOT analysis of Sun Pharmaceutical Industries Ltd.•Understanding of – planning strategies, organisation structure, control and leadership style of the company.•Various strategies implemented in order to get listed in the list of best place to work at.

SWOT ANALYSIS •Expertise in relatively

complex generic pharmaceuticals•Low cost generic portfolio•Successful acquisitions over years•Strong brand presence in India and US•Strong marketing and sales force

Strength

SWOT ANALYSIS

Drug Price Control order puts undue pressure on product prices, affecting the profitability of the pharmaceutical companies.Strick govt. regulation & policies afeect operational efficiencyOffice politics & too much departmentalisation.

Weakness

SWOT ANALYSIS •Increase healthcare

awareness in urban and rural India•Enhance product basket and market presence•Further acquisitions will help in tapping the emerging global market

Opportunities

SWOT ANALYSIS •Stiff competition in generic

markets from other low cost rivals like Cipla , Lupin, Dr. Reddy’s Lab•The company being more into acquisition based growth might lead to a stage of financial crunch as it has already happened in the case of Caraco pharma where it provided debt to Caraco and is facing problems due to the continuous losses made by the latter.•Stringent patent regulations

Threats

PLANNING STRATEGIES

Mission- Good health and happiness for all.

Vision- With good health to all as a primary objective, Sun Pharmacy started with an aims to be among top 10 Generic pharmacies and OTC player in India with the help of strategic growth and stringent quality measures.

PLANNING STRATEGIES

ORGANISATION STRUCTURE

SUN PHARMA FOLLOWS A FUNCTIONAL UNITARY STRUCTUREStructured around a CEO and limited corporate staffActivities are grouped together by common functionEach functional unit has different set of duties and responsibilitiesSpecialisation is built into the organisational structure

ORGANISATION STRUCTURE

Various organising teams are-An wide range of specialists and world class doctorsFinancial audit teamOperation teamThe R & D centres are supported by around 2000 scientists and cutting edge technologies

WHAT IS LATEST ON SUN PHARMA?

Revenues US 4.2 billion

DETAILS OF MERGERIn April 2014 the Sun Pharma took over RanbaxyThe deal was set at US 4.2 billion approx.The merger will help Sun Pharma to enhance its presence in emerging pharma markets like Russia, Brazil, South Africa and also for better brand building.

CONTROL MECHANISM The company has a well established internal control framework

Global audit team function carries out risk focused audits across all business(both India and Global)

Operational management team closely monitors internal environment & ensures that the recommendations are effectively implemented

Evaluation of performance of the board, its committee and every individual directors are also done.

LEADERSHIP STYLEDilip Shanghvi , founder and Managing Director Sun Pharma, along with his team of CEOs, presidents, vice-presidents and other senior officials of the merged entity shoulder responsibilities to take the company to the next level. Sr. Officials maintain a cordial relationship among each other and also with their sub-ordinates in order to reach quick decisions.

The MD engaged several world class managers to head his overseas venture in order to build strong management capabilities .

Despite suffering losses due to overseas acquisitions , the MD believes in not changing the top management.

WHY SUN PHARMA IS THE BEST PLACE TO WORK

COMPANY’S STRATEGIES

“Attracting the right talent and engaging them for high performance”- focus of the company.

In order to be placed in the list of best place to work at, the company implies various strategies with respect to work culture, employee benefits and HR policies.

THE VARIOUS STRATEGIES ARE-

•Training and self development activities to enhance and enrich employee knowledge and skills.•Remuneration policy for directors, key managerial officials and other employees.•Aimed in providing each personnel an environment free from discrimination and harassment of any kind.

CONCLUSION

As Sun Pharma being a leading pharmaceutical company , it needs to work on its drawbacks to retain its market share in the global market.As Sun pharma has acquisition based growth, many a times the organisation fails to recover back its cost. So they should have a market research team which can give them an overall idea regarding the firms which they plan to acquire.Sun Pharma is a global leader in the pharmaceuticals industry but it lack presence in the European market. So in order to extend its reach the company can tie up with medium scale pharmaceutical companies of European market Product differentiation and innovation also play a key role in order to compete with its competitor and retain its top position in the global market.